Literature DB >> 10670584

Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1.

J A Hamilton1, R Byrne, G Whitty.   

Abstract

The mode of action of immunological adjuvants is not yet completely understood. Many are particulate. Certain antigen-presenting (dendritic) cell populations belong to the monocyte/macrophage lineage and, like other members of the lineage, in some tissues appear to be short-lived. We report that many poorly degradable, particulate adjuvants, for example, aluminum hydroxide, oil-in-water emulsions, calcium phosphate, and silica, enhance murine bone marrow-derived macrophage survival; induction of DNA synthesis was even observed. No evidence could be found for a requirement for endogenous granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage-CSF (M-CSF or CSF-1). Synergy for the proliferative effects was noted in the presence of added GM-CSF or CSF-1. It is suggested from these in vitro findings that one function of certain particulate adjuvants may be to increase by enhanced survival or even proliferation the number of cells available for subsequent antigen presentation and cytokine production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10670584

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

Review 1.  Use of defined TLR ligands as adjuvants within human vaccines.

Authors:  Malcolm S Duthie; Hillarie Plessner Windish; Christopher B Fox; Steven G Reed
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 3.  Glial grafting for demyelinating disease.

Authors:  V Tepavcević; W F Blakemore
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

4.  Macrophagic myofasciitis: characterization and pathophysiology.

Authors:  R K Gherardi; F J Authier
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

5.  Nanoparticle Internalization Promotes the Survival of Primary Macrophages.

Authors:  Bader M Jarai; Catherine A Fromen
Journal:  Adv Nanobiomed Res       Date:  2022-02-09

6.  Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth.

Authors:  Bikul Das; Roula Antoon; Rika Tsuchida; Shamim Lotfi; Olena Morozova; Walid Farhat; David Malkin; Gideon Koren; Herman Yeger; Sylvain Baruchel
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

7.  A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro.

Authors:  Theresa N Andersson; Gunilla J Ekman; Hans Grönlund; Eva Buentke; Tove L J Eriksson; Annika Scheynius; Marianne Van Hage-Hamsten; Guro Gafvelin
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

8.  Hypoxia enhances the proliferative response of macrophages to CSF-1 and their pro-survival response to TNF.

Authors:  John A Hamilton; Derek C Lacey; Amanda Turner; Bernard de Kok; Jennifer Huynh; Glen M Scholz
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

9.  Inflammatory microcrystals induce murine macrophage survival and DNA synthesis.

Authors:  J A Hamilton; G McCarthy; G Whitty
Journal:  Arthritis Res       Date:  2001-03-26

10.  Slow CCL2-dependent translocation of biopersistent particles from muscle to brain.

Authors:  Zakir Khan; Christophe Combadière; François-Jérôme Authier; Valérie Itier; François Lux; Christopher Exley; Meriem Mahrouf-Yorgov; Xavier Decrouy; Philippe Moretto; Olivier Tillement; Romain K Gherardi; Josette Cadusseau
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.